BVI shares new Beyeonics One technology during ASCRS 2022

Conferences|ASCRS

Shervin Korangy, CEO of BVI, shares about the company's new technology, Beyeonics One, on display during ASCRS 2022.

Related Videos
Related Content

World No Tobacco Day 2023: Smoking linked to early vision loss and eye diseases

May 30th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

New approach to foveal holes: Light, sound, and nutraceuticals

May 24th 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Focusing on laser trabeculoplasty, the glaucoma workhorse

May 16th 2023

Norlase receives FDA 510(k) clearance and CE Mark approval for laser photocoagulator

May 13th 2023

World No Tobacco Day 2023: Smoking linked to early vision loss and eye diseases

May 30th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

New approach to foveal holes: Light, sound, and nutraceuticals

May 24th 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Focusing on laser trabeculoplasty, the glaucoma workhorse

May 16th 2023

Norlase receives FDA 510(k) clearance and CE Mark approval for laser photocoagulator

May 13th 2023

World No Tobacco Day 2023: Smoking linked to early vision loss and eye diseases

May 30th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

New approach to foveal holes: Light, sound, and nutraceuticals

May 24th 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Focusing on laser trabeculoplasty, the glaucoma workhorse

May 16th 2023

Norlase receives FDA 510(k) clearance and CE Mark approval for laser photocoagulator

May 13th 2023
© 2023 MJH Life Sciences

All rights reserved.